Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
公司代碼SMTI
公司名稱Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)
員工數量141
證券類型Ordinary Share
年結日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編76102
電話18175292300
網址https://sanaramedtech.com/
公司代碼SMTI
上市日期Apr 07, 1994
CEOMuppalla (Suresh V)